F. Leitner
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 16
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 17
- Microbial Natural Products and Biosynthesis 3
- Clinical Biochemistry top 10%
- Microbiology top 10%
-
- Antimicrobial Resistance in Staphylococcus 10
-
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Pneumonia and Respiratory Infections 2
-
- Phenothiazines and Benzothiazines Synthesis and Activities 3
- Cancer therapeutics and mechanisms 3
- Co-authors
- M MisiekK. E. PriceT. A. PursianoR. E. BuckR E KesslerSidney CohenHelen M. SweeneyJ V Desiderio
- Journals
- Antimicrobial Agents and Chemotherapy (11 papers)The Journal of Antibiotics (4 papers)Journal of Bacteriology (3 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
F. Leitner
28 papers receiving 454 citations
Peers
Comparison fields: 5 of 74
- Molecular Medicine 259
- Pharmacology 394
- Applied Microbiology and Biotechnology 32
- Clinical Biochemistry 49
- Microbiology 42
Countries citing papers authored by F. Leitner
This map shows the geographic impact of F. Leitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Leitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Leitner more than expected).
Fields of papers citing papers by F. Leitner
This network shows the impact of papers produced by F. Leitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Leitner. The network helps show where F. Leitner may publish in the future.
Co-authorship network
The 12 scholars most cited alongside F. Leitner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 141 | |
| 2 | 1982 | 13 | |
| 3 | 1980 | 7 | |
| 4 | 1979 | 14 | |
| 5 | 1976 | 43 | |
| 6 | 1975 | 19 | |
| 7 | 1973 | 24 | |
| 8 | 1973 | 7 | |
| 9 | 1973 | 9 | |
| 10 | 1972 | 66 | |
| 11 | 1972 | 3 | |
| 12 | Laboratory studies with a new cephalosporanic acid derivative. | 1969 | 14 |
| 13 | 1969 | 4 | |
| 14 | 1969 | 11 | |
| 15 | Microbiological and pharmacological evaluation of BL-C 43, a new semisynthetic derivative of coumermycin A1. | 1969 | 1 |
| 16 | 1967 | 6 | |
| 17 | 1967 | 10 | |
| 18 | 1965 | 1 | |
| 19 | 1965 | 10 | |
| 20 | 1962 | 9 |
About F. Leitner
F. Leitner is a scholar working on Molecular Medicine, Pharmacology, Applied Microbiology and Biotechnology, Infectious Diseases and Microbiology, having authored 29 papers that have together received 562 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (16 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Microbial Natural Products and Biosynthesis (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Cancer therapeutics and mechanisms (3 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Molecular Medicine (259 citations), Pharmacology (394 citations), Applied Microbiology and Biotechnology (32 citations), Clinical Biochemistry (49 citations) and Microbiology (42 citations). F. Leitner has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include M Misiek, K. E. Price, T. A. Pursiano, R. E. Buck, R E Kessler, Sidney Cohen, Helen M. Sweeney, J V Desiderio, R. S. Hirth and Yu-Huan Tsai. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics, Journal of Bacteriology, Journal of Antimicrobial Chemotherapy and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.